Common Variable Immunodeficiency

Watchlist

(log in to enable)

Retrieved

2022-04-26

Source

Gard

Trials

—

Genes

ICOS, NFKB2, TNFRSF13B, CD19, CR2, TNFRSF13C, NFKB1, CD81, MS4A1, CTLA4, IL21, IKZF1, IRF2BP2, TNFSF12, PRKCD, IL2RA, HAVCR1, GPR35, FGF14, LAMB4, ADGRL2, SRPX, ATXN2L, FUT2, CRB1, CARD9, ERAP2, TNFSF15, ZNF630, ZMIZ1, CDK14, MAN1C1, ATG16L1, NKD1, IGF2-AS, TNF, SMAD3, ADCY7, SUOX, ANKRD55, FNBP1, IRF1-AS1, C1orf141, KANTR, LINC00993, LINC01250, GNG12-AS1, ANKRD30A, DAG1, INS-IGF2, OR14J1, LRRK2, IL23R, TAB3, SNX31, LURAP1L, CACNA1C, CD27, TNFSF13B, CD40LG, FOXP3, SH2D1A, BTK, IL10, TLR9, TNFSF13, IL6, IL2, IFNG, LRBA, CD40, TLR4, BCL2, HLA-A, ANP32B, MBL2, TLR2, RAG1, CCR7, IGAD1, TRBV20OR9-2, STAT3, IL4, AICDA, ISG20, IFNA1, IFNA13, SBDS, VAV1, FCGR2A, APCS, FCGR3A, ICOSLG, TNFRSF8, FCGR3B, FCGRT, IGHG3, BCL6, POMC, BCR, SERPINA1, HLA-DQB1, IRF4, MTA2, TNFRSF18, HLA-C, IL22, ADIPOQ, CD38, CD86, TBX19, EBI3, ACTB, SWAP70, CLEC16A, CENPX, NLRP12, IL33, CARD11, NEIL1, NOD2, SCYL1, ARHGEF7, IFNK, KRT20, TOLLIP, TLR7, ADIPOR1, ASCC1, IL21R, NT5C, IGHV3-75, CLDN15, SMUG1, CLDN2, PRKAR1A, IL18R1, GEM, DPP4, DUSP5, CELSR3, FCN2, FUS, GATA3, HFE, CHIT1, HLA-B, HLA-DQA1, HLA-DRB1, HLA-DRB3, HSPG2, IL5, DNMT1, CDH13, IL17A, CXCR5, AIC, XIAP, FAS, AR, TNFRSF17, BLK, CAMLG, CD70, CASP3, CASP9, CD1D, CD14, CD28, CD69, IL7, ITGAM, BHLHE40, TCOF1, CCL19, CCL21, XCL1, SDC1, STAT5A, STAT5B, TERT, PTPRC, TNFRSF1B, TP53, UCHL1, VDR, XBP1, CDR3, RAG2, POU2AF1, ITGAX, MPO, ITK, KIR2DS1, KIR3DL1, KIR3DL2, LCK, LTA, MRC1, PIK3CD, MSH5, MYD88, NCAM1, NEDD9, ORC4, PAX5, H3P40

Drugs

—

Interested in hearing about new therapies?

Common variable immunodeficiency (CVID) is a group of disorders characterized by low levels of a type of protein known as immunoglobulins (Ig). Because of low level of Ig, the immune system cannot make antibodies that fight bacteria, viruses or other toxins in the body. This leads to frequent infections, particularly in the sinuses, lungs, and digestive tract. Symptoms most commonly begin in early adulthood but can occur at any age. While in most cases the cause of CVID is unknown, a genetic change has been found in about one-third of cases. This condition is diagnosed based on the symptoms, specific laboratory testings, and exclusion of other disorders. Treatment for CVID includes Ig replacement therapy, which stops the cycle of recurrent infections. The long term outlook for people with CVID varies depending on the severity of the symptoms and any underlying conditions.